Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
RespireRx Pharmaceuticals Announces Collaboration with University College London (UCL)
Thursday, April 06, 2023RespireRx Pharmaceuticals announced that it has entered into a material transfer agreement with University College London UCL As part of the collaboration the RespireRx research team will be working to study the possibility of using CX RespireRxs lea...
InflaRx Announces FDA Emergency Use Authorisation for Gohibic (vilobelimab)
Wednesday, April 05, 2023InflaRx announced that Gohibic vilobelimab a firstinclass monoclonal antihuman complement factor Ca antibody has been granted an Emergency Use Authorisation EUA by the US Food and Drug Administration FDA for the treatment of coronavirus disease COVI...
Pfizer Announces FDA Acceptance of Supplemental New Drug Application
Wednesday, April 05, 2023Pfizer announced today that the US Food and Drug Administration FDA has accepted for review the Supplemental New Drug Applications sNDAs for BRAFTOVI encorafenib MEKTOVI binimetinib for patients with metastatic nonsmall cell lung cancer NSCLC with a...
Solvay Collaborates with Ginkgo Bioworks
Wednesday, April 05, 2023Solvay announced a strategic collaboration with Ginkgo Bioworks Through this multiyear strategic collaboration agreement Solvay will join forces with Ginkgo to unlock the power of synthetic biology as an enabler of more sustainable chemicals and mate...
Scorpion Therapeutics Announces Collaboration and Licence Agreement with Pierre Fabre
Wednesday, April 05, 2023Scorpion Therapeutics and Pierre Fabre announced an exclusive collaboration and licence agreement for the codevelopment of STX and STX two candidates in Scorpions franchise of highlyselective nextgeneration mutant epidermal growth factor receptor EGF...
Sandoz Announces European Commission Approval for Hyrimoz® (adalimumab)
Tuesday, April 04, 2023Sandoz announced that the European Commission EC granted marketing authorisation in the European Union EU for a citratefree high concentration formulation HCF mgmL of biosimilar Hyrimoz adalimumab The adalimumab citratefree HCF mgmL formulation off...
BioNTech Partners with Duality Biologics
Tuesday, April 04, 2023BioNTech and Duality Biologics announced that the companies have entered into exclusive licence and collaboration agreements for two ADC assets to develop manufacture and commercialise the two assets globally excluding Mainland China Hong Kong Specia...
Genenta Science Announces Extension of Licence Agreement with Ospedale San Raffaele
Tuesday, April 04, 2023Genenta announced that the licence agreement with Ospedale San Raffaele OSR has been amended and restated to provide access to all solid tumour indications subject to governmental consent as described below This agreement will strengthen the breadth...
Eisai Enters into Agreement with National Cancer Centre
Tuesday, April 04, 2023Eisai announced that it has entered into an agreement with the National Cancer Centre to collaborate on investigatorinitiated clinical research for the EZH inhibitor tazemetostat hydrobromide generic name product name Tazverik Tablets mg tazemetosta...
Merck Announces Approval of KEYTRUDA® in Combination with Padcev®
Tuesday, April 04, 2023Merck announced the US Food and Drug Administration FDA has approved KEYTRUDA Mercks antiPD therapy in combination with Padcev enfortumab vedotinejfv for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma lamUC w...
